Rebetol
ribavirin
Hepatitis C, Chronic
Date of authorisation:
Revision: 39
Last updated:
MedicineHumanWithdrawn
EMEA-002535-PIP04-21 - paediatric investigation plan
Decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Therapeutic area: Infectious diseases
PIP number: P/0370/2022
Route(s) of administration: Oral useIntravenous use
Pharmaceutical form(s):
Tablet
Powder for oral solution
Powder for solution for injection or infusion
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
Ribavirin Teva Pharma B.V.
ribavirin
Hepatitis C, Chronic
Date of authorisation:
Revision: 14
Last updated:
MedicineHumanWithdrawn
Ribavirin Teva
ribavirin
Hepatitis C, Chronic
Date of authorisation:
Revision: 15
Last updated:
MedicineHumanWithdrawn
Ribavirin BioPartners
ribavirin
Hepatitis C, Chronic
Date of authorisation:
Revision: 2
Last updated:
MedicineHumanLapsed
Ribavirin - paediatric investigation plan
Decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Therapeutic area: Gastroentology-Hepatology
PIP number: P/63/2008
Route(s) of administration: Oral use
Pharmaceutical form(s):
Oral solution and Hard Capsules
Decision date:
Last updated:
Compliance check: ✔
PIPHuman
Cotronak
ribavirin
Hepatitis C, Chronic
Date of authorisation:
Revision: 4
Last updated:
MedicineHumanWithdrawn